Catalyst Wire Dossier Catalyst Wire Dossier

bivalent influenza peptide-conjugate vaccine

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bivalent influenza peptide-conjugate vaccine, covering 2015-02-12 to 2015-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of a Bivalent Influenza Peptide Conjugate Vaccine in Healthy Adults [Phase 1]

See pricing